Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads

Human Reproduction

Volumn 19, Issue 6, 2004, Pages 1338-1344

  Rajpert De Meyts, Ewa ^a   Hanstein, Regina ^a,b   Jørgensen, Niels ^a   Græm, Niels ^a   Vogt, Peter H ^b   Skakkebæk, Niels E ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Germ cell differentiation; OCT 3; OCT 4; POU5F1; Testicular carcinoma in situ

Indexed keywords

OCTAMER BINDING PROTEIN 3; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ARTICLE; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO CELL; FEMALE; FETUS; FETUS CELL; GENE EXPRESSION; GENE SILENCING; GERM CELL; GESTATIONAL AGE; GONADAL DYSGENESIS; GONADOBLASTOMA; HERMAPHRODITISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MEIOSIS; OOCYTE; OVARY DISEASE; OVARY FOLLICLE CELL; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; SEX DIFFERENTIATION DISORDER; SPERMATOGONIUM; TESTIS DISEASE; TOTIPOTENT STEM CELL;

EID: 3042643365     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh265     Document Type: Article

References (32)

1. Brehm A, Ovitt CE and Schöler HR (1998) Oct-4: more than just a POUerful marker of the mammalian germline? APMIS 106,114-126.
2. Forest MG, Cathiard AM and Bertrand JA (1973) Evidence of testicular activity in early infancy. J Clin Endocrinol Metab 37,148-151.
3. Gidekel S, Pizov G, Bergman Y and Pikarsky E (2003) Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4,361-370.
4. Goto T, Adjaye J, Rodeck CH and Monk M (1999) Identification of genes expressed in human primordial germ cells at the time of entry of the female germ line into meiosis. Mol Hum Reprod 5,851-860.
5. Hadziselimovic F, Thommen L, Girard J and Herzog B (1986) The significance of postnatal gonadotropin surge for testicular development in normal and cryptorchid testes. J Urol 136,274-276.
6. Hansis C, Grifo JA and Krey LC (2000) Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod 6,999-1004.
7. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E and Skakkebæk NE (2003) Histological evidence of testicular dysgenesis in contralateral biopsies of 218 patients with testicular germ cell cancer. J Pathol 200,370-374.
8. Hustin J, Collette J and Franchimont P (1987) Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl 10,29-35.
9. Jacobsen GK and Norgaard-Pedersen B (1984) Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study. APMIS [A] 92,323-329.
10. Jørgensen N, Rajpert-De Meyts E, Græm N, Müller J, Giwercman A and Skakkebæk NE (1995) Expression of immunohistochemical markers for testicular carcinoma-in situ by normal human fetal germ cells cells. Lab Invest 72,223-231.
11. Kleinsmith LJ and Pierce GB (1964) Multipotentiality of single embryonal carcinoma cells. Cancer Res 24,1544-1551.
12. Looijenga LHJ, Stoop H, de Leeuw HPJ, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H et al (2003) POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63,2244-2250.
13. Niwa H, Miyazaki J and Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24,372-376.
14. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M and Hamada H (1990) A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60,461-472.
15. Palmieri SL, Peter W, Hess H and Schöler HR (1994) Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol 166,259-267.
16. Palumbo C, van Roozendaal K, Gillis AJ, van Gurp RH, de Munnik H, Oosterhuis JW, van Zoelen EJ and Looijenga LH (2002) Expression of the PDGF α-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms. J Pathol 196,467-77.
17. Pan GJ, Chang ZY, Schöler HR and Pei D (2002). Stem cell pluripotency and transcription factor Oct4. Cell Res 12,321-329.
18. Pesce M, Wang X, Wolgemuth DJ and Schöler HR (1998) Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech Dev 71,89-98.
19. Rajpert-De Meyts E and Skakkebæk NE (1994) Expression of the c-kit protein product in carcinoma-in situ and invasive testicular germ cell tumours. Int J Androl 17,85-92.
20. Rajpert-De Meyts E, Jørgensen N, Müller J, and Skakkebæk NE (1996) Prolonged expression of the c-kit receptor in germ cells of the intersex fetal testes. J Pathol 178,166-169.
21. Rajpert-De Meyts E, Jørgensen N, Nielsen KB, Müller J and Skakkebæk NE ( 1998) Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 106,198-206.
22. Rajpert-De Meyts E, Jørgensen NE, Græm N, Müller J, Cate R and Skakkebæk NE (1999) Expression of anti-Müllerian hormone during normal and pathological gonadal development: Association with differentiation of Sertoli and granulosa cells. J Clin Enclocrinol Metab 84,3836-3844.
23. Rajpert-De Meyts E, Bartkova J, Samson M, Hoei-Hansen CE, Frydelund-Larsen L, Bartek J, and Skakkebæk NE (2003) The emerging phenotype of the testicular carcinoma in situ cell. APMIS 111,267-279.
24. Robinson LLL, Gaskell T, Saunders TK and Anderson RAA (2001) Germ cell specific expression of c-kit in the human fetal gonad. Mol Hum Reprod 7,845-852.
25. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW and Staudt LM (1990) A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345,686-692.
26. Schöler HR, Hatzopoulos AK, Balling R, Suzuki N and Gruss P (1989) A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J 8,2543-2550.
27. Schöler HR, Dressler G, Balling R, Rohdewohld H and Gruss P (1990) Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J 9,2185-2195.
28. Sharpe RM, Mckinnell C, Kivlin C and Fisher JS (2003) Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125,769-784.
29. Skakkebæk NE (1972) Possible carcinoma-in-situ of the testis. Lancet ii,516-517.
30. Skakkebæk NE, Berthelsen JG, Giwercman A and Müller J (1987) Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10,19-28.
31. Skakkebæk NE, Rajpert-De Meyts E and Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16,972-978.
32. Skakkebæk NE, Hoei-Hansen CE, Holm M, Jørgensen N and Rajpert-De Meyts E (2003) Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS 111,1-11.